P1156: magnify phase 3b study of lenalidomide + rituximab (r2) followed by maintenance in relapsed/refractory indolent non-hodgkin lymphoma: complete induction phase analysisF. Lansigan,D. J. Andorsky,M. Coleman,A. Yacoub,J. M. Melear,S. R. Fanning,K. S. Kolibaba,C. Reynolds,G. S. Nowakowski,M. Gharibo, J. R. Ahn, J. Li,M. J. Rummel,J. P. SharmanHemaSphere（2022）引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
